Yukiko Yasuoka
Overview
Explore the profile of Yukiko Yasuoka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shimada Y, Izumi Y, Yasuoka Y, Oshima T, Nagaba Y, Nanami M, et al.
Int J Mol Sci
. 2024 Sep;
25(17).
PMID: 39273415
Many large-scale studies revealed that exogenous erythropoietin, erythropoiesis-stimulating agents, have no renoprotective effects. We reported the renoprotective effects of endogenous erythropoietin production on renal function in ischemic reperfusion injury (IRI)...
2.
Yasuoka Y, Izumi Y, Fukuyama T, Oshima T, Yamazaki T, Uematsu T, et al.
Int J Mol Sci
. 2024 Jan;
25(2).
PMID: 38279224
Many large-scale studies show that exogenous erythropoietin, erythropoiesis-stimulating agents, lack any renoprotective effects. We investigated the effects of endogenous erythropoietin on renal function in kidney ischemic reperfusion injury (IRI) using...
3.
Characterization of gene expression in the kidney of renal tubular cell-specific NFAT5 knockout mice
Ono M, Izumi Y, Maruyama K, Yasuoka Y, Hiramatsu A, Aramburu J, et al.
Am J Physiol Renal Physiol
. 2023 Dec;
326(3):F394-F410.
PMID: 38153851
Nuclear factor of activated T cells 5 (NFAT5; also called TonEBP/OREBP) is a transcription factor that is activated by hypertonicity and induces osmoprotective genes to protect cells against hypertonic conditions....
4.
Yasuoka Y, Izumi Y, Sands J, Kawahara K, Nonoguchi H
Molecules
. 2023 Jun;
28(11).
PMID: 37298922
Detection of erythropoietin (Epo) was difficult until a method was developed by the World Anti-Doping Agency (WADA). WADA recommended the Western blot technique using isoelectric focusing (IEF)-PAGE to show that...
5.
Yasuoka Y, Izumi Y, Fukuyama T, Omiya H, Pham T, Inoue H, et al.
Molecules
. 2022 Feb;
27(3).
PMID: 35164384
Anemia is a major complication of chronic renal failure. To treat this anemia, prolylhydroxylase domain enzyme (PHD) inhibitors as well as erythropoiesis-stimulating agents (ESAs) have been used. Although PHD inhibitors...
6.
Yasuoka Y, Izumi Y, Fukuyama T, Inoue H, Oshima T, Yamazaki T, et al.
Molecules
. 2021 Sep;
26(17).
PMID: 34500833
The kidney is a main site of erythropoietin production in the body. We developed a new method for the detection of Epo protein by deglycosylation-coupled Western blotting. Detection of deglycosylated...
7.
Eguchi K, Izumi Y, Yasuoka Y, Nakagawa T, Ono M, Maruyama K, et al.
J Endocrinol
. 2021 Mar;
249(2):95-112.
PMID: 33705345
Rhesus C glycoprotein (Rhcg), an ammonia transporter, is a key molecule in urinary acid excretion and is expressed mainly in the intercalated cells (ICs) of the renal collecting duct. In...
8.
Yasuoka Y, Fukuyama T, Izumi Y, Yamashita T, Nakayama Y, Inoue H, et al.
Heliyon
. 2020 Nov;
6(11):e05389.
PMID: 33195841
Doping tests for the illegal use of erythropoiesis-stimulating agents (ESAs) have been developed. We developed a new Western blotting method to detect and distinguish endogenous erythropoietin (Epo, 35-38 kDa) and...
9.
Yasuoka Y, Fukuyama T, Izumi Y, Nakayama Y, Inoue H, Yanagita K, et al.
Physiol Rep
. 2020 Jun;
8(12):e14485.
PMID: 32592328
The detection of erythropoietin (Epo) protein by Western blotting has required pre-purification of the sample. We developed a new Western blot method to detect plasma and urinary Epo using deglycosylation....
10.
Tamura S, Yasuoka Y, Miura H, Takahashi G, Sato M, Ohtsuka M
Exp Anim
. 2020 Feb;
69(3):287-294.
PMID: 32051391
The pronuclear injection (PI)-based targeted transgenesis (PITT) method allows the generation of targeted transgenic (Tg) mice wherein a single copy of a transgene is integrated into the Rosa26 locus following...